ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding ARS Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 188 | 188 | 0 |
| Shares | 84.5M | 83.6M | −888.6K (−1.1%) |
| Value | $1.48B | $840.4M | −$634.6M (−43.0%) |
New holders (43)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (43)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.